Two cases of COVID-19 Kappa variant detected in UP: How is this different from Delta variant

-

The state of Uttar Pradesh on Friday reported two special cases of the Kappa variant of the 2019 novel coronavirus. The two cases have been confirmed by King George’s Medical College in Uttar Pradesh where the genome sequencing of 109 samples took place recently.

According to an official report, out of the 109 samples taken by experts, 107 Delta Plus variant cases were found. While some reports claim that there were three cases of Kappa variant in the state. This, after the first patient detected with this variant, a 66-year-old resident, has reportedly succumbed to the disease.

The state's Additional Chief Secretary (Health) Amit Mohan Prasad, however, said that "there is nothing to worry" as treatment is possible for these variants of coronavirus. Prasad also informed that these were the not first cases, as such "variants were found in the state earlier as well".

Meanwhile, a statement issued after Chief Minister Yogi Adityanath's COVID-19 review meeting said that the facility of genome sequencing is being increased in the state.

What is Genome sequencing?

It is a laboratory process where experts are involved in characterising the mutations and tracking disease outbreaks. Currently, the daily positivity rate in Uttar Pradesh is 0.04 percent.

According to the Union Health Ministry’s recent report, there were 16,238 Delta and Kappa, 3,969 Alpha, one Gamma, and 149 Beta variant cases all over the country.

What is Kappa variant?

The Kappa variant of coronavirus, according to World Health Organisation (WHO), was first detected in India in October 2020. Since then, the variant has been identified as B.1.617.1 while Delta is signified as B.1.617.2. This variant is also not a new one. So far, the WHO has not termed the Kappa variant as a concern but only as a ‘variant of interest’.

What is the main difference between Delta and Kappa?

Both these variants have been reported first in India in October 2020. The Delta became a variant of concern in May this year while Kappa is termed to be a variant of interest only on 4 April.

So far, Kappa is referred to as a double mutant. However, the Delta variant has emerged as a threat across the world. In fact, the second wave of the COVID-19 pandemic that hit India was also because of the Delta variant.



from Firstpost India Latest News https://ift.tt/36o2DV4
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more